| |
| |
|
| Insider
Information: |
Litalien James J |
| Relationship: |
SrVP/Chief Reg&Quality... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
64,164 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,164 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Sr. V-P, Reg Affairs &... |
2004-06-02 |
0 |
2004-05-28 |
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
SVP Regulatory Affairs... |
2009-02-17 |
64,164 |
2007-10-08 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
SrVP/Chief Reg&Quality... |
2018-05-15 |
0 |
2018-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-05-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,800) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-04-02 |
4 |
AS |
$117.10 |
$597,213 |
D/D |
(5,000) |
3,800 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-04-02 |
4 |
OE |
$18.17 |
$90,850 |
D/D |
5,000 |
8,800 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-01-16 |
4 |
AS |
$101.99 |
$532,619 |
D/D |
(5,000) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
SrVP/Chief Reg&Quality Officer |
• – – |
2018-01-16 |
4 |
OE |
$18.17 |
$90,850 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP Regulatory Affairs & QA |
• – – |
2009-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,952 |
64,164 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP Regulatory Affairs & QA |
• – – |
2008-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
43,212 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP Regulatory Affairs & QA |
• – – |
2008-04-14 |
4 |
D |
$4.66 |
$8,332 |
D/D |
(1,788) |
18,212 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP Regulatory Affairs & QA |
• – – |
2007-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-06-02 |
4 |
S |
$20.82 |
$12,735 |
D/D |
(611) |
0 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-06-02 |
4 |
OE |
$7.91 |
$4,833 |
D/D |
611 |
111 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-06-01 |
4 |
S |
$20.75 |
$70,322 |
D/D |
(3,389) |
0 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-06-01 |
4 |
OE |
$7.91 |
$26,807 |
D/D |
3,389 |
3,389 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-05-28 |
4 |
S |
$20.25 |
$81,353 |
D/D |
(4,000) |
0 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Sr. V-P, Reg Affairs & Comp. |
• – – |
2004-05-28 |
4 |
OE |
$7.91 |
$31,640 |
D/D |
4,000 |
100 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
